Wolverine Asset Management
DMAA icon

Wolverine Asset Management’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Wolverine Asset Management’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.27M Buy
851,989
+19,896
+2% +$214K 0.06% 233
2026
Q2 		$8.86M Sell
832,093
-721,615
-46% -$7.64M 0.08% 214
2026
Q1 		$16.3M Buy
1,553,708
+246,240
+19% +$2.57M 0.16% 138
2025
Q4 		$13.6M Buy
1,307,468
+58,340
+5% +$602K 0.11% 198
2025
Q3 		$12.8M Buy
1,249,128
+227,222
+22% +$2.33M 0.09% 206
2025
Q2 		$10.4M Buy
1,021,906
+418,868
+69% +$4.24M 0.1% 207
2025
Q1 		$6.04M Buy
+603,038
New +$6.03M 0.07% 270

Other funds holding DMAA

Mizuho Securities USA
Mizuho Securities USA New York $6.3B AUM 30.7% 1-Year Est. Return
Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.34B AUM 3.39% 1-Year Est. Return
First Trust Capital Management
First Trust Capital Management Chicago, Illinois $2.08B AUM 59.2% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 22.91% 1-Year Est. Return
Crossingbridge Advisors
Crossingbridge Advisors Pleasantville, New York $571M AUM 0.32% 1-Year Est. Return
RLH Capital
RLH Capital Great Neck, New York $277M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Dakota Wealth Management
Dakota Wealth Management Palm Beach Gardens, Florida $5.38B AUM 27.63% 1-Year Est. Return
Arax Advisory Partners
Arax Advisory Partners Denver, Colorado $17.7B AUM 20.22% 1-Year Est. Return

Wolverine Asset Management's DMAA Position: Q3 2026 in Review

Wolverine Asset Management increased its Drugs Made In America Acquisition Corp (DMAA) stake by 2.4% in Q3 2026, buying an estimated $214K and bringing the position to 851,989 shares worth $9.27M. The position accounts for 0.06% of the portfolio, ranked #233.

Wolverine Asset Management first reported a position in DMAA in Q1 2025 and has held it in 7 quarters since. The position peaked at $16.3M in Q1 2026. 12 funds tracked by Wall St. Rank hold DMAA as of Q3 2026.

  • Wolverine Asset Management held 851,989 shares of Drugs Made In America Acquisition Corp worth $9.27M as of Q3 2026.
  • Wolverine Asset Management bought 19,896 Drugs Made In America Acquisition Corp shares in Q3 2026, an estimated $214K.
  • Drugs Made In America Acquisition Corp made up 0.06% of Wolverine Asset Management's portfolio in Q3 2026, its #233 holding.
  • Wolverine Asset Management first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and has held it in 7 quarters since.
  • Wolverine Asset Management's Drugs Made In America Acquisition Corp position peaked at $16.3M in Q1 2026.
  • 12 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.